Cytokinetics, Incorporated (CYTK Quick QuoteCYTK - Free Report) was a big mover last session, as the company saw its shares rise over 10% on the day. The upside was driven after the company reported third-quarter net income of $31.9 million on Oct 27. The news also led to far more shares changing hands than in a normal session, resulting in solid volume. This reverses the recent trend of the company, as the stock is now trading above the volatile price range of $8.83 to $9.65 in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days, while the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cytokinetics carries a Zacks Rank #2 (Buy).

CYTOKINETCS INC Price

 

CYTOKINETCS INC Price | CYTOKINETCS INC Quote

Another favorably-ranked stock in the same industry is Adocia S.A. (ADOCY Quick QuoteADOCY - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CYTK going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>